Evidence map›Paper›PMID 41415279›Full record

ReviewFrontiers in immunology2025

Structural and dynamic properties of IL1 receptors.

J V Zhukova, J A Lopatnikova, S V Sennikov

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J V ZhukovaLaboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), Novosibirsk, Russia.
J A LopatnikovaLaboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), Novosibirsk, Russia.
S V SennikovLaboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), Novosibirsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of the structural and dynamic properties of multidomain proteins is of great interest as they constitute one of the main regulatory mechanisms in the ligand-receptor system. The interleukin-1 (IL-1) family is a group of proinflammatory, pleiotropic cytokines whose activity is primarily mediated through two primary signaling receptors-the IL-1 type I receptor (IL-1R1) and the IL-1 receptor accessory protein (IL-1R3), which acts as a coreceptor-and a decoy receptor, the IL-1 type II receptor (IL-1R2). Their key ligands include the agonists IL-1α and IL-1β, and the endogenous antagonist IL-1 receptor antagonist (IL-1Ra). Evaluating the interdomain movements of these receptors is expected to shed light on the mechanisms of ligand binding and the development of a functional cellular response. Furthermore, analysis of the literature allows us to identify key aspects of the conformational dynamics of IL-1 receptors. It is established that the flexibility of the domains of these receptors plays a crucial role in their ability to adapt to various ligands and ensure accurate signal transmission in the cell. Analysis of the structural and functional features of these receptors allows us to determine the mechanisms underlying their interactions and identify differences in their functional activities. Understanding the structural mechanisms that give rise to domain flexibility can enable us to develop molecules which are capable of specifically modulating the activity of these receptors. This facet is especially important in the context of treating inflammatory and autoimmune diseases for the creation of new approaches to therapy.

Indexed as

Receptors, Interleukin-1Receptors, Interleukin-1 Type IAnimalsHumansLigandsProtein BindingProtein ConformationSignal TransductionLigandsReceptors, Interleukin-1Receptors, Interleukin-1 Type Iconformational dynamicsIL-1 receptorsinterdomain flexibilitymolecular mechanismsmulti-domain proteins

Identifiers

PMID41415279
PMCPMC12708590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.